Reporting J1444 under ESRD PPS
In the quarterly update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), a new HCPCS Level II code is being added for anemia management with an effective date of July 1, 2019.
J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
This code is subject to Medicare Part B consolidated billing and, therefore, ESRD facilities will not receive separate payment for J1444 with or without modifier AY Item or service furnished to an ESRD patient that is not for the treatment of ESRD.
As will all drugs and biologicals that are furnished to ESRD patients via dialysate solution, append modifier JE Administered via dialysate to J1444 on bill type 72x.
MLN Matters MM11215
Latest posts by Renee Dustman (see all)
- CMS Approves 10 New Drug Codes - May 23, 2019
- Identifiers To Be Stricken From Medicare Standard Paper Remit - May 22, 2019
- Checklists Facilitate eCQM Specifications Update - May 21, 2019